

LONDON, April 29 (Reuters) - Strong demand for hyperactivity treatment Vyvanse helped lift first-quarter earnings 12 percent at Shire, the London-list...


* StanChart, Tullow, Weir, Shire and Reckitt in firing line * Fund firms call for "common sense" in remuneration planning * Opposition follows revolts...


(ShareCast News) - Shire shareholders voted to approve the pay of the drug maker's top directors on Thursday, but only just. At the annual general mee...


BRUSSELS, April 28 (Reuters) - The following are mergers under review by the European Commission and a brief guide to the EU merger process: APPROVALS...